Coronavirus disease (COVID-19) is an infectious disease caused by the coronavirus SARS-CoV-2. Here we have collected APR news related to the COVID-19 pandemic, vaccination efforts and emerging treatments.
Wednesday, April 06, 2022
Sotrovimab is no longer authorized to treat COVID-19 in any U.S. region due to increases in the proportion of COVID-19 cases caused by the Omicron BA.2 sub-variant.
read more
CanSino Biologics Inc. announced that the National Medical Products Administration of China ("NMPA") granted approval for the clinical trial application of its COVID-19 mRNA vaccine in China.
read more
Merck announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date of the supplemental biologics license application (sBLA) for VAXNEUVANCE™
read more
Novavax, Inc. announced submission of its request to expand the conditional marketing authorization (CMA) of Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) in the European Union (EU) to ...
read more
The Centers for Disease Control and Prevention (CDC) Nowcast data from March 29, 2022 estimates that the proportion of COVID-19 cases caused by the Omicron BA.2 variant is above 50% in three ...
read more
Wednesday, March 30, 2022
The FDA authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals.
read more
AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination, has been granted marketing authorization in the European Union (EU) for the pre-exposure ...
read more
Novavax, Inc. announced that NVX-CoV2373, its protein-based COVID-19 vaccine, is included in two trials now underway to evaluate its vaccine's safety, immunogenicity, and reactogenicity as a booster ...
read more
New tools are urgently needed to control the current out-of-control COVID-19 pandemic which can be further complicated by annually emerging influenza infections, especially in the winter months.
read more
Wednesday, March 23, 2022
Thermo Fisher Scientific Inc., announced its collaboration with the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Initiative, Helix, and Rosalind aimed at developing a ...
read more
The FDA is announcing a virtual meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Wed., April 6, to discuss considerations for future COVID-19 vaccine booster ...
read more
Health Canada authorized the use of the Moderna Spikevax (50 mcg) COVID-19 vaccine in children 6 to 11 years of age. This is the second COVID-19 vaccine authorized in Canada for use in this younger ...
read more
The Medicines Patent Pool (MPP) announced that it has signed agreements with 35 companies to manufacture the generic version of Pfizer's oral COVID-19 treatment nirmatrelvir, which in combination with...
read more
Pfizer Inc. and BioNTech SE announced the companies have submitted an application to the FDA for Emergency Use Authorization (EUA) of an additional booster dose adults 65 years of age and older who ...
read more
Akston Biosciences Corporation and Biolexis, a division of Stelis Biopharma Limited have entered into a licensing, manufacturing and commercialization agreement for Akston’s AKS-452, a protein subunit...
read more